Evidence map›Paper›PMID 39630441›Full record

ArticleJAMA surgery2025

Effects of Pancreatic Fistula After Minimally Invasive and Open Pancreatoduodenectomy.

Caro L Bruna, Anouk M L H Emmen, Kongyuan Wei, Robert P Sutcliffe, Baiyong Shen, Guiseppe K Fusai, Yi-Ming Shyr, Igor Khatkov, Steve White, Leia R Jones and 14 more

Abstract readMulticenter StudyComment
In one paragraph

Article in JAMA surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Caro L BrunaDepartment of General Surgery, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Anouk M L H EmmenDepartment of General Surgery, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Kongyuan WeiFaculty of Hepato-Biliary-Pancreatic Surgery, Chinese People's Liberation Army (PLA) General Hospital, Institute of Hepatobiliary Surgery of Chinese PLA, Key Laboratory of Digital Hepatobiliary Surgery, PLA, Beijing, China.
Robert P SutcliffeDepartment of Hepatopancreatobiliary and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Baiyong ShenDepartment of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Guiseppe K FusaiDepartment of HPB Surgery and Liver Transplantation, Clinical Service of HPB Surgery and Liver Transplantation, Royal Free London NHS Foundation Trust, London, United Kingdom.
Yi-Ming ShyrGeneral Surgery, Department of Surgery, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China.
Igor KhatkovDepartment of Surgery, Moscow Clinical Scientific Center, Moscow, Russia.
Steve WhiteDepartment of Hepatobiliary, Pancreatic and Transplant Surgery, Department of Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Leia R JonesDepartment of General Surgery, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Alberto ManzoniDepartment of General Surgery, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Mustafa KeremDepartment of General Surgery, Gazi University, School of Medicine, Ankara, Turkey.
Bas Groot KoerkampDepartment of Surgery, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.
Clarissa FerrariResearch and Clinical Trials Office, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Olivier Saint-MarcDepartment of Surgery, Centre Hospitalier Regional Orleans, Orleans, France.
I Quintus MolenaarDepartment of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
Claudio BnàDepartment of Radiology, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Safi DokmakDepartment of HPB Surgery and Liver Transplantation, Beaujon Hospital, University Paris Cite, Clichy, France.
Ugo BoggiDepartment of Surgery, University Hospital of Pisa, Pisa, Italy.
Rong LiuFaculty of Hepato-Biliary-Pancreatic Surgery, Chinese People's Liberation Army (PLA) General Hospital, Institute of Hepatobiliary Surgery of Chinese PLA, Key Laboratory of Digital Hepatobiliary Surgery, PLA, Beijing, China.
Jin-Young JangDepartments of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Marc G BesselinkAmsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
Mohammad Abu HilalDepartment of General Surgery, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
International Consortium on Minimally Invasive Pancreatic Surgery (I-MIPS)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Postoperative pancreatic fistulas (POPF) are the biggest contributor to surgical morbidity and mortality after pancreatoduodenectomy. The impact of POPF could be influenced by the surgical approach. Objective: To assess the clinical impact of POPF in patients undergoing minimally invasive pancreatoduodenectomy (MIPD) and open pancreatoduodenectomy (OPD). Design, Setting, and Participants: This cohort study was conducted from 2007 to 2020 in 36 referral centers in Europe, South America, and Asia. Participants were patients with POPF (grade B/C as defined by the International Study Group of Pancreatic Surgery [ISGPS]) after MIPD and OPD (MIPD-POPF, OPD-POPF). Propensity score matching was performed in a 1:1 ratio based on the variables age (continuous), sex, body mass index (continuous), American Society of Anesthesiologists score (dichotomous), vascular involvement, neoadjuvant therapy, tumor size, malignancy, and POPF grade C. Data analysis was performed from July to October 2023. Exposure: MIPD and OPD. Main Outcomes and Measures: The primary outcome was the presence of a second clinically relevant (ISGPS grade B/C) complication (postpancreatic hemorrhage [PPH], delayed gastric emptying [DGE], bile leak, and chyle leak) besides POPF. Results: Overall, 1130 patients with POPF were included (558 MIPD and 572 OPD), of whom 336 patients after MIPD were matched to 336 patients after OPD. The median (IQR) age was 65 (58-73) years; there were 703 males (62.2%) and 427 females (37.8%). Among patients who had MIPD-POPF, 129 patients (55%) experienced a second complication compared with 95 patients (36%) with OPD-POPF (P < .001). The rate of PPH was higher with MIPD-POPF (71 patients [21%] vs 22 patients [8.0%]; P < .001), without significant differences for DGE (65 patients [19%] vs 45 patients [16%]; P = .40), bile leak (43 patients [13%] vs 52 patients [19%]; P = .06), and chyle leak (1 patient [0.5%] vs 5 patients [1.9%]; P = .39). MIPD-POPF was associated with a longer hospital stay (median [IQR], 27 [18-38] days vs 22 [15-30] days; P < .001) and more reoperations (67 patients [21%] vs 21 patients [7%]; P < .001) but comparable in-hospital/30-day mortality (25 patients [7%] vs 7 patients [5%]; P = .31) with OPD-POPF, respectively. Conclusions and Relevance: This study found that for patients after MIPD, the presence of POPF is more frequently associated with other clinically relevant complications compared with OPD. This underscores the importance of perioperative mitigation strategies for POPF and the resulting PPH in high-risk patients.

Indexed as

Minimally Invasive Surgical ProceduresPancreatic FistulaPancreaticoduodenectomyPostoperative ComplicationsAgedFemaleHumansMaleMiddle AgedPropensity ScoreRetrospective Studies

Identifiers

PMID39630441
PMCPMC11618579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.